Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3177 |
Orexin 2 Receptor Agonist
OX2R |
OX Receptor | GPCR/G Protein; Neuroscience |
Orexin 2 Receptor Agonist (OX2R) 是一种选择性有效的OX2R 激动剂, EC50为23 nM。 | |||
T39561 |
Orexin 2 Receptor Agonist 2
|
||
Orexin 2 Receptor Agonist 2 (ORA-2) is a specific agonist for the orexin 2 receptor. | |||
T39229 |
YNT-185
|
OX Receptor | GPCR/G Protein; Neuroscience |
YNT-185 是一种非肽类、选择性的俄睾丸激素2型受体(OX2R)激动剂,对 OX2 R和 OX1R 的 EC50 值分别为 0.028 μM 和 2.75 μM。此外,YNT-185 在小鼠模型中有效缓解了嗜睡症-猝倒症的症状。 | |||
T39808 | Firazorexton | ||
Firazorexton is a potent orexin type 2 receptor (OX2R) agonist. | |||
TP1975L |
[Ala11,D-Leu15]-Orexin B acetate
[Ala11,D-Leu15]-Orexin B acetate (532932-99-3 Free base) |
OX Receptor | GPCR/G Protein; Neuroscience |
[Ala11,D-Leu15]-Orexin B acetate 是一种特异性 orexin-2 受体 (OX2) 激动剂,EC50 为 0.13 nM,比 OX1 (52 nM) 特异性高 400 倍。 | |||
T75922 |
OXA(17-33) TFA
|
||
OXA(17-33) TFA,一种高效且选择性的orexin-1 receptor (OX1)激动剂,其对OX1 (EC50=8.29 nM) 的选择性是对OX2 (187 nM) 的23倍。 | |||
T75921 |
[Ala11,D-Leu15]-Orexin B(human) TFA
|
||
[Ala11,D-Leu15]-Orexin B(human) TFA为高效的orexin-2 receptor (OX2)选择性激动剂。其对OX2展现出比OX1 (52 nM) 高达400倍的较高选择性(EC50=0.13 nM)。 | |||
T37112 |
YNT-185 dihydrochloride
|
||
Potent and selective orexin OX2 receptor agonist (EC50 = 28 nM at human OX2 expressed in CHO cells). Displays approximately 100-fold selectivity for OX2 over OX1 (EC50 = 2.75 μM at human OX1 expressed in CHO cells). Depolarizes OX2-expressing histaminergic neurons in mouse brain slices. Increases wake time in wild type mice. Suppresses cataplexy-like symptoms in OX knockout mice. Nagahara et al (2015) Design and synthesis of non-peptide, selective orexin receptor 2 agonists. J.Med.Chem. 58 7931 ... | |||
T75925 |
Orexin B, rat, mouse TFA
|
||
Orexin B, rat, mouse (Rat orexin B) TFA,作为一种内源性促进食欲的(Orexin receptor)激动剂,通过结合并激活两个亲密相关的孤儿G蛋白偶联受体OX1-R和OX2-R,促进食物摄入和能量消耗,并在睡眠-觉醒调节中扮演关键角色。 | |||
T78636 |
Firazorexton hydrate
TAK-994 |
||
Firazorexton hydrate (TAK-994)为一种高效的食欲素2型受体(OX2R)激动剂,EC50值为19 nM。在发作性睡病小鼠模型中,该化合物能够有效减少觉醒碎片和猝倒样发作的发生。 |